Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE3609.9029.95 (+0.84 %)

PREV CLOSE ( ) 3579.95

OPEN PRICE ( ) 3558.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2205

TODAY'S LOW / HIGH ( )3558.15 3639.25

52 WK LOW / HIGH ( )2891.45 3790

NSE3612.9033.8 (+0.94 %)

PREV CLOSE( ) 3579.10

OPEN PRICE ( ) 3581.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 3612.90 (88)

VOLUME 166143

TODAY'S LOW / HIGH( ) 3558.80 3639.00

52 WK LOW / HIGH ( )2886.45 3787.9

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

31780

29590

28090

28890

Total Expenditure

21460

19950

18950

19500

PBIDT (Excl OI)

10320

9640

9140

9390

Other Income

-370

-180

330

-160

Operating Profit

9950

9460

9470

9230

Interest

560

570

640

Exceptional Items

-240

0.00

PBDT

9390

8660

8900

8590

Depreciation

2010

1990

1980

Profit Before Tax

7380

6650

6910

6610

Tax

1900

1670

1880

2080

Provisions and contingencies

Profit After Tax

5480

4980

5030

4530

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

5480

4980

5030

4530

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

5480

4980

5030

4530

Equity Capital

1692.3

Face Value (IN RS)

Reserves

Calculated EPS

16.19

14.71

14.86

13.38

Calculated EPS (Annualised)

64.76

58.85

59.44

53.53

No of Public Share Holdings

107260040

97316000

% of Public Share Holdings

31.69

28.75

PBIDTM% (Excl OI)

32.47

32.57

32.53

32.50

PBIDTM%

31.30

31.97

33.71

31.94

PBDTM%

29.54

29.26

31.68

29.73

PBTM%

23.22

22.47

24.59

22.87

PATM%

17.24

16.83

17.90

15.68

Notes

Risk Disclosures on Derivatives

Quarterly Results

TORRENT PHARMACEUTICALS LTD.